CIPO Patents = 1

EPO Patents = 1

Forward Citations = 1

Loading Chart...

3 inventors (with patents filed for the assignee):

Joanne Holland (5 out of 17 patents)

Christopher Frampton (4 out of 12 patents)

Alex Eberlin (2 out of 21 patents)

4. Daniel Gooding (8 patents)

5. Alan Chorlton (5 patents)

5 patents: Sort by Forward Citations

1. 12084399 - Crystalline tranilast salts and their pharmaceutical use (2024-09-10),

2. 12049452 - Olaparib hydroxybenzoic acid cocrystals and their pharmaceutical use (2024-07-30),

3. 12012386 - Olaparib oxalic acid cocrystals and their pharmaceutical use (2024-06-18),

4. 11078155 - Crystalline tranilast salts and their pharmaceutical use (2021-08-03),

5. 10150729 - Tranilast compositions and cocrystals (2018-12-11),

Nuformix Technologies Limited is a pharmaceutical development company focused on bringing innovative drug treatments to market. With a unique approach to drug discovery using cocrystal technology, Nuformix is able to enhance the therapeutic properties of existing drugs. Their mission is to provide patients with improved treatment options for a range of medical conditions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#156 in Cambridge

#3,210 in United Kingdom

Cambridge, United Kingdom

Nuformix Technologies Limited

Forward Citations = 1

3 inventors:

Joanne Holland (5 out of 17 patents)

Christopher Frampton (4 out of 12 patents)

Alex Eberlin (2 out of 21 patents)

4. Daniel Gooding (8 patents)

5. Alan Chorlton (5 patents)

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]